Table of Contents Table of Contents
Previous Page  515 / 1082 Next Page
Information
Show Menu
Previous Page 515 / 1082 Next Page
Page Background

S500

ESTRO 36 2017

_______________________________________________________________________________________________

Agility

®

collimator system included 160 MLC, minimum

leaf width was 5 mm. MLC effective speed was 6.5 cm/sec

and leaf travel was 15cm over the central axis. VMAT plans

were generated on Monaco 5.1

®

(Crawley, Elekta)

treatment planning system with Monte Carlo algorithm. All

calculation parameters were grid spacing 0.3

cm, minimum segment width 1.0 cm, Max. 180 of control

Points Per Arc, Fluence smoothing medium, Statistical

Uncertainty 1% per plan, increment of gantry 30° and dose

to medium.

The VMAT-TBI tecnique consisted of three isocentres and

three dual overlapping arcs from top of head to the

bottom of pelvis region. The prescribed dose was 90% of

target volume receiving dose of 12Gy. Mean dose to lung

and kidney were restricted less than 10Gy and maximum

dose to lens were restricted less than 6Gy. The plans were

verified using 2D array IBA Matrixx

®

and CC13 ion chamber.

The comparison between calculation and measurement

were made by γ-index (3%-3mm) analysis and absolute

dose measurement at the isocentre.

Results

An average total delivery time was determined 923±34

seconds and an average monitor unit (MU)s was

determined 2614±231MUs for dual arc VMAT technique.

When we evaluated organ at risk(OAR)s, mean dose to

lungs was 9.7±0.2Gy, mean dose to kidneys was

8.8±0.3Gy, maximum dose to lens was 5.5±0.3Gy and

maximum point dose was 14.6±0.3Gy, HI of PTV was

1.13±0.2, mean dose to PTV was 12.6±0.15Gy and mean γ-

index (%3-3mm) pass rate was %97.1±1.9. Absolute doses

were measured by CC13 ion chamber and we determined

%2.0±0.6 dose difference between measurement and

treatment planning system's (TPS) calculation at the

isocentre.

Conclusion

The results show that dose coverage of target and OAR’s

doses are feasible for TBI using VMAT tecnique on the

coach. A benefit could be demonstrated with regard to

dose distribution and homogeneity and dose-reduction to

organs at risk. Additionally,we determined highly precise

dose delivery by patient QA and point dose measurement

at the isocentre. Based on the dose distributions we have

decided to plan TBI in our clinic with dual arc VMAT

technique on the treatment coach.

PO-0911 Can the therapeutic benefits of microbeam

radiation therapy be achieved using a clinical linac?

N. Suchowerska

1

, V. Peng

1

, L. Rogers

1

, E. Claridge-

Mackonis

1

, D.R. McKenzie

2

1

Chris O'Brien Lifehouse, Radiation Oncology,

Camperdown- Sydney, Australia

2

University of Sydney, School of Physics, Sydney,

Australia

Purpose or Objective

The increasing availability of high definition multileaf

collimators (HDMLCs) with 2.5mm leaves provides an

opportunity for ‘grid’ therapy to more closely approach

the clinical outcomes of Microbeam Radiation Therapy

(MRT). However, periodic spatial modulation of the dose

in the target volume runs counter to current clinical

practice. To optimize the modulation, a better

understanding of cell dose responses to such treatments is

needed. The aim of this study is to determine if some of

the therapeutic benefits of MRT can be achieved using a

clinical linac with HDMLCs and if so, to develop a

predictive model to optimize the benefits of such

treatments.

Material and Methods

Varian Novalis Tx

TM

HD120-MLCs were used to generate

grid patterns of 2.5mm and 5.0mm spacing, which were

dosimetrically characterized using Gafchromic

TM

EBT3 film

[Figure 1]. Clonogenic survival of normal (HUVEC) and

cancer (lung NCI-H460, breast HCC-1954, melanoma

MM576) cell lines were compared in vitro for the same

average dose, following irradiation with periodically

modulated and open 6MV photon fields.

Results

Survival of normal cells in a 2.5mm striped field was the

same as for an open field, but the survival of the cancer

cells was significantly lower. However for cancer cell lines

in the 5.0mm modulated fields, the response compared to

an open field was no longer statistically significant. A

mathematical model was developed to incorporate the

dose gradients of the spatial modulation into the standard

linear quadratic model. Our new extended bystander LQ

model assumes spatial gradients drive the diffusion of

soluble factors that influence survival through bystander

effects. The model successfully predicts the experimental

results that show an increased therapeutic benefit.

Conclusion

We have confirmed that HDMLCs can create spatially

modulated fields that increase the therapeutic advantage

between normal and cancer cells. Our results challenge

conventional radiotherapy practice and propose that

additional gain can be realized by prescribing spatially

modulated treatments to harness the bystander effect.

PO-0912 Short- and long term stability of the isocenter

of a three-source Co60 MR guided radiotherapy device

D. Hoffmans

1

, M.A. Palacios

1

, J.P. Cuijpers

1

1

VU University Medical Center, Radiotherapy,

Amsterdam, The Netherlands

Purpose or Objective

Recently a 0.35T Co

60

MRIdian system (Viewray Inc.,

Cleveland) is implemented at our institution. In a similar

way as for other image guided radiotherapy techniques,

the coincidence of the radiation therapy (RT) and imaging

isocenter is of major importance. The purpose of this

study is to present a method for daily QA of MR-RT

isocenter coincidence and to assess its short- and long

term stability using daily film-based isocenter QA.

Material and Methods

Two pieces of radiochromic film (GafChromic EBT3) are

taped to square inlays on the top and the side of a cubic

water-filled phantom. The phantom is aligned to the MRI

isocenter using MR guided setup relying on three internal

cylindrical markers.

A treatment plan, consisting of an AP and a lateral square

field is delivered. The direction of the lateral field is

altered daily between 90

o

and 270

o

in order to monitor all

3 treatment heads (Head 1 and 2 for the lateral fields

respectively, head 3 for the AP field). The films are

digitized and the positions of the square fields with

respect to the phantom are determined. These data

provide a daily measurement of the coincidence of the RT-

and MR- isocenters in 3 dimensions. The AP field provides